Lifestyle Features

Pennsylvania measles-associated deaths climb to four as outbreak grows

The Pennsylvania Department of Health on Tuesday reported two more measles-associated deaths, both in unvaccinated individuals, bringing the state's total fatalities linked to the disease outbreak to four.

Pennsylvania measles-associated deaths climb to four as outbreak grows

Most Recent

.js-only { display: none; } .queue_story .image_box:before, #loadMoreStories, .browseday { display: none; }

This country is paying its people to read. Can it stop 'brain rot'?

This country is paying its people to read. Can it stop 'brain rot'?

Kathleen Magramo, CNN | Updated Sept. 15 - 3:04 p.m. | Save Story

Whether it's while waiting for the train or chilling solo at a cafe, a tiny nation in Southeast Asia is nudging its people toward an increasingly elusive habit: reading.

Legend Biotech taps Novartis veteran Zhang as CEO

Legend Biotech taps Novartis veteran Zhang as CEO

Siddhi Mahatole, Reuters | Updated Sept. 15 - 2:22 p.m. | Save Story

Legend Biotech on Tuesday appointed longtime Novartis executive Ingrid Zhang as its CEO, effective immediately, banking on an industry veteran to steer its expansion beyond blockbuster cancer therapy Carvykti.

American incomes finally top pre-pandemic levels, fighting against inflation all the way

American incomes finally top pre-pandemic levels, fighting against inflation all the way

Christopher Rugaber, Associated Press | Posted Sept. 15 - 1:43 p.m. | Save Story

Household income finally topped pre-pandemic levels last year, a stark sign of how the past five years of rising prices have limited Americans' earnings and purchasing power.

For the first time, Japan has more than 100,000 centenarians

For the first time, Japan has more than 100,000 centenarians

Chris Lau and Junko Ogura, CNN | Updated Sept. 15 - 11:36 a.m. | Save Story

Japan has been gripped by a declining population for decades, but one age group is adding new members, and there are more of them than ever — centenarians.

Novo CEO urges staff to embrace more customer-focused culture

Novo CEO urges staff to embrace more customer-focused culture

Jacob Gronholt-Pedersen, Reuters | Updated Sept. 15 - 11:32 a.m. | Save Story

Novo Nordisk's CEO Mike Doustdar on Tuesday urged employees to be more customer-focused, as the Wegovy maker seeks to regain ground ‌in the fast-growing obesity drug market.

Exclusive-Healthcare software firm Waystar explores options including sale, sources say

Exclusive-Healthcare software firm Waystar explores options including sale, sources say

Isla Binnie, Sabrina Valle and Milana Vinn, Reuters | Updated Sept. 15 - 11:24 a.m. | Save Story

Software provider Waystar, whose products are used by hospitals and doctors to manage payments, is exploring options including a potential sale that could return it to private hands two years after a stock market listing in ‌New York, seven sources familiar with the matter said.

UN sees some progress in Congo Ebola fight, but too early to call peak

UN sees some progress in Congo Ebola fight, but too early to call peak

Reuters | Updated Sept. 15 - 6:02 a.m. | Save Story

U.N. officials said on Tuesday that efforts to curb Ebola in eastern Congo were beginning to show results but stressed that the epidemic remained "massive" and would take months to bring under control.

Scholar Rock says its first muscle-targeted SMA therapy will cost about $310,000 annually

Scholar Rock says its first muscle-targeted SMA therapy will cost about $310,000 annually

Reuters | Updated Sept. 14 - 12:55 p.m. | Save Story

Scholar Rock on Monday said the net annual cost of its newly approved spinal muscular atrophy treatment will be about $310,000 for a typical patient, after the drug became the first ‌therapy approved to directly target muscle loss associated with the rare genetic disorder.

BioNTech says lung cancer drug candidate prolonged lives in trial

BioNTech says lung cancer drug candidate prolonged lives in trial

Reuters | Updated Sept. 14 - 2:15 a.m. | Save Story

BioNTech said on Monday that a late-stage ‌trial showed its drug ⁠candidate gotistobart led ⁠to a clinically ‌meaningful overall ‌survival benefit in ⁠a ⁠certain form of lung cancer compared with standard treatment.

How Salt Lake travelers feel about TSA's new Gateside program

How Salt Lake travelers feel about TSA's new Gateside program

Emily Walker, Deseret News | Posted Sept. 13 - 3:33 p.m. | Save Story

Travelers shared their thoughts on TSA's new Gateside program that allows access to gate areas in 13 airports across the country, including Salt Lake City.

GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports

GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports

Reuters | Updated Sept. 13 - 9:40 a.m. | Save Story

GE HealthCare Technologies is in talks over a possible $1 billion deal to buy radiopharmaceutical developer Sofie ‌Biosciences, the Financial Times reported on Sunday, citing ⁠people familiar with the matter.

Scholar Rock gets first FDA nod for rare muscle-wasting disease

Scholar Rock gets first FDA nod for rare muscle-wasting disease

Sneha S K and Christy Santhosh, Reuters | Updated Sept. 11 - 4:59 p.m. | Save Story

The U.S. Food and Drug Administration approved Scholar Rock's therapy on Friday to treat a rare genetic condition that causes muscle weakness, marking the first regulatory approval for the ‌company.

AstraZeneca's breast cancer pill fails in late-stage trial

AstraZeneca's breast cancer pill fails in late-stage trial

Christy Santhosh, Reuters | Updated Sept. 11 - 4:31 p.m. | Save Story

AstraZeneca's breast cancer pill failed to meet the main goal of improving progression-free survival in a late-stage trial, the company said on Friday, a week after the treatment received U.S. approval.

AbbVie's menstrual migraine treatment meets late-stage study goal

AbbVie's menstrual migraine treatment meets late-stage study goal

Reuters | Updated Sept. 10 - 9:14 a.m. | Save Story

AbbVie said on Thursday its migraine treatment had in a late-stage study reduced the migraine days associated ‌with the menstrual period.

US FDA reports 22 cases of salmonella infections linked to broccoli sprouts

US FDA reports 22 cases of salmonella infections linked to broccoli sprouts

Reuters | Updated Sept. 10 - 9:07 a.m. | Save Story

The U.S. Food and Drug Administration said on Wednesday it was investigating a multistate outbreak of salmonella infections linked to broccoli sprouts, the latest in a series of foodborne-illness investigations ‌involving produce.

Evommune scraps eczema drug after trial miss, shares plunge

Evommune scraps eczema drug after trial miss, shares plunge

Reuters | Updated Sept. 9 - 9:12 a.m. | Save Story

Evommune said on Tuesday it will not advance its experimental skin disease drug after it failed to meet the main goal in ‌a mid-stage trial, sending its shares down 24% in aftermarket ⁠trading.

Weight Watchers names Stephen Bye as CEO

Weight Watchers names Stephen Bye as CEO

Reuters | Updated Sept. 9 - 8:48 a.m. | Save Story

WW International on Wednesday named Stephen Bye as its chief executive officer, effective this ‌fall.

Roivant's experimental lung disease drug meets goals in mid-stage study

Roivant's experimental lung disease drug meets goals in mid-stage study

Sahil Pandey, Reuters | Updated Sept. 9 - 3:23 a.m. | Save Story

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients with high blood pressure associated with a type of lung disease, sending shares up ‌about 17%.

Amgen-AstraZeneca lung cancer drug combo boosts survival in late-stage trial

Amgen-AstraZeneca lung cancer drug combo boosts survival in late-stage trial

Reuters | Updated Sept. 8 - 2:26 p.m. | Save Story

Amgen's targeted immunotherapy, Imdelltra, combined with AstraZeneca's cancer drug Imfinzi, significantly improved overall survival in patients with extensive-stage small-cell lung cancer in a late-stage trial, the companies said on ‌Tuesday.